Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA

Six Minute Walk Test Acceptable as Primary Efficacy Endpoint for Potential Registration ProgramSOUTH SAN ...

MPX Receives Final Court Approval for Arrangement with iAnthus

NEW YORK and TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ...

Quell Reports Successful CES 2019

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix (Nasdaq: NURO) today announced a ...

Quell Reports Successful CES 2019

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix (Nasdaq: NURO) today announced a ...